AbbVie Inc. logo ABBV - AbbVie Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 26
HOLD 12
SELL 1
STRONG
SELL
0
| PRICE TARGET: $258.63 DETAILS
HIGH: $289.00
LOW: $240.00
MEDIAN: $257.00
CONSENSUS: $258.63
UPSIDE: 20.66%
Market Cap: 378.84B
Volume: 7,864,128
Avg Volume: 5,881,238
52 Week Range: 164.39-244.81
Sector: Healthcare
Industry: Drug Manufacturers - General
Beta: 0.35
Last Dividend: $6.92
Exchange: NYSE
Country: US
Employees: 55,000
IPO Date: 2013-01-02
EPS (TTM): 2.40
P/E Ratio: 73.48
Revenue (TTM): 56.33B
Total Assets: 135.16B
Total Debt: 67.84B
Cash & Equiv: 5.52B
Rev Growth (5Y): 11.1%
EPS Growth (5Y): -14.6%
FCF Growth (5Y): 6.9%
ROCE: 6.8%
Debt/Equity: 20.40

Track Record

Statements >
Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013
Revenue 56.33B 54.32B 58.05B 56.20B 45.80B 33.27B 32.75B 28.22B 25.64B 22.86B 19.96B 18.79B
Net Income 4.28B 4.86B 11.84B 11.54B 4.62B 7.88B 5.69B 5.31B 5.95B 5.14B 1.77B 4.13B
EPS 2.40 2.73 6.65 6.48 2.73 5.30 3.69 3.31 3.65 3.15 1.11 2.58
Total Assets 135.16B 134.71B 138.81B 146.53B 150.56B 89.11B 59.35B 70.79B 66.10B 53.05B 27.51B 29.20B
Total Debt 67.84B 60.12B 64.19B 77.58B 87.06B 67.09B 40.31B 37.37B 36.84B 31.67B 15.01B 14.72B
Cash & Equivalents 5.52B 12.81B 9.20B 9.75B 8.45B 39.92B 7.29B 9.30B 5.10B 8.40B 8.35B 9.60B
Operating Cash Flow 18.81B 22.84B 24.94B 22.78B 17.59B 13.32B 13.43B 9.96B 7.04B 7.54B 3.55B 6.27B
Free Cash Flow 17.83B 22.06B 24.25B 21.99B 16.79B 12.77B 12.79B 9.43B 6.56B 7.00B 2.94B 5.78B
FCF per Share 10.08 12.48 13.69 12.42 10.07 8.62 8.30 5.91 4.05 4.31 1.84 3.63
Book Value 3.33B 10.36B 17.25B 15.41B 13.08B (8.17B) (8.45B) 5.10B 4.64B 3.94B 1.74B 4.49B
Cash & ST Investments 5.55B 12.82B 9.23B 9.83B 8.48B 39.92B 8.06B 9.79B 6.42B 8.41B 8.37B 9.89B
ROC Equity 1.29 0.47 0.69 0.75 0.35 N/A N/A 1.04 1.28 1.30 1.02 0.92